Index of reports
> Cases with Anaemia (16)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinorelbine where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-08-08
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-30
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-08-30
Possible Vinorelbine side effects in female
Reported by a physician from Japan on 2012-07-31
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Subdural Haematoma, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
End date: 2012-07-19
Afinitor
Dosage: 10 mg, unk
Administration route: Oral
Start date: 2012-07-24
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-13
End date: 2012-07-13
Vinorelbine
Start date: 2012-07-24
Comparator Trastuzumab
Indication: Breast Cancer
Start date: 2012-03-13
End date: 2012-07-19
Zoledronic Acid
Indication: Metastases To Bone
Start date: 2011-05-01
Comparator Trastuzumab
Start date: 2012-07-24
Other drugs received by patient: Loxoprofen; Lansoprazole; Rebamipide; Lyrica; Fentanyl-100; Magmitt
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-07-25
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-28
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-29
Possible Vinorelbine side effects in female
Reported by a physician from Japan on 2012-07-25
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Subdural Haematoma, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-13
End date: 2012-07-13
Zoledronic Acid
Dosage: unk
Indication: Metastases To Bone
Start date: 2012-03-13
Comparator Trastuzumab
Dosage: unk
Start date: 2012-03-13
Vinorelbine
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
Other drugs received by patient: Loxoprofen; Lansoprazole; Lyrica; Rebamipide; Magmitt; Fentanyl-100
Possible Vinorelbine side effects in female
Reported by a physician from Japan on 2012-07-19
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Subdural Haematoma, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zoledronic Acid
Dosage: unk
Indication: Metastases To Bone
Start date: 2012-03-13
Vinorelbine
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
Afinitor
Dosage: 5 mg, qd
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-13
Comparator Trastuzumab
Dosage: unk
Indication: Breast Cancer Metastatic
Start date: 2012-03-13
Other drugs received by patient: Magmitt; Loxoprofen; Rebamipide; Lansoprazole; Lyrica; Fentanyl-100
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-07-09
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-28
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-29
Possible Vinorelbine side effects in
Reported by a physician from United States on 2012-07-06
Patient:
Reactions: Respiratory Failure, Anaemia, Neutropenia, Thrombocytopenia, Infection
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Vinorelbine
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Colony Stimulating Factor
Dosage: on day 9 of each cycle
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Gemcitabine
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Possible Vinorelbine side effects in 63 year old male
Reported by a consumer/non-health professional from Germany on 2012-06-28
Patient: 63 year old male
Reactions: Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cetuximab
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-06
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-06
Vinorelbine
Indication: non-Small Cell Lung Cancer
Start date: 2005-10-06
Possible Vinorelbine side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27
Patient:
Reactions: Respiratory Failure, Anaemia, Neutropenia, Thrombocytopenia, Infection
Drug(s) suspected as cause:
Vinorelbine
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Gemcitabine
Dosage: administered on day 1 and day 8 of every 21 day cycle
Indication: Diffuse Large B-Cell Lymphoma
Colony Stimulating Factor
Dosage: on day 9 of each cycle
Indication: Diffuse Large B-Cell Lymphoma
Possible Vinorelbine side effects in
Reported by a physician from United States on 2012-06-22
Patient:
Reactions: Thrombosis, Device Related Infection, Headache, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hyperglycaemia, Anaemia, Hypotension, Dehydration, Neutropenia, Bone Pain, Pain, Hypokalaemia, Disease Progression, Death, Postoperative Wound Infection, Fatigue, Neutropenic Infection, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Alanine Aminotransferase Increased, Lymphopenia, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Diarrhoea, Arthralgia, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Docetaxel
Dosage: 60 mg/m2, unk
Indication: Breast Cancer Metastatic
Vinorelbine
Dosage: 27.5 mg/m2, per chemo regim
Indication: Breast Cancer Metastatic
Filgrastim
Dosage: 5 mug/kg, per chemo regim
Indication: Breast Cancer Metastatic
Trastuzumab
Dosage: 2 mg/kg, qwk
Trastuzumab
Dosage: 4 mg/kg, one time dose
Indication: Breast Cancer Metastatic
Possible Vinorelbine side effects in 54 year old male
Reported by a consumer/non-health professional from Germany on 2012-05-25
Patient: 54 year old male
Reactions: Diarrhoea, Anaemia, Dehydration
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-01
Cetuximab
Dosage: 250mg/m2, 1 in 1 week
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-01
End date: 2005-09-09
Cetuximab
Vinorelbine
Indication: non-Small Cell Lung Cancer
Start date: 2005-09-01
Possible Vinorelbine side effects in 65 year old male
Reported by a consumer/non-health professional from Ireland on 2012-05-23
Patient: 65 year old male
Reactions: Diarrhoea, Anaemia, Dehydration, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: non-Small Cell Lung Cancer
Start date: 2005-07-20
Vinorelbine
Indication: non-Small Cell Lung Cancer
Start date: 2005-07-20
Cetuximab
Indication: non-Small Cell Lung Cancer
Start date: 2005-07-20
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-03-20
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-29
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-28
Possible Vinorelbine side effects in female
Reported by a physician from Czech Republic on 2012-02-22
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Vomiting, Diarrhoea, Anaemia, Chest Pain, Pyrexia, Decreased Appetite
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Comparator Trastuzumab
Dosage: 126 mg, qw
Start date: 2012-02-01
Afinitor
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-17
End date: 2012-01-23
Comparator Trastuzumab
Dosage: 126 mg, qw
Indication: Breast Cancer Metastatic
Start date: 2011-08-17
End date: 2012-01-24
Blinded NO Treatment Received
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-17
End date: 2012-01-23
Blinded Placebo
Dosage: code not broken
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-17
End date: 2012-01-23
Vinorelbine
Dosage: 41 mg, qw
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-17
End date: 2012-01-18
Other drugs received by patient: Indap; Neurontin; Zolpidem; Omeprazole; Atenolol
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-02-03
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-12-28
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-12-28
Possible Vinorelbine side effects in female
Reported by a physician from Poland on 2012-01-27
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vinorelbine
Dosage: 20mgm2 cyclic
Indication: Breast Cancer Metastatic
Start date: 2011-08-30
Lapatinib
Dosage: 1250mg per day
Administration route: Oral
Indication: Breast Cancer Metastatic
Start date: 2011-08-30
|